TP53 and gastric adenocarcinoma: Recent molecular classification studies have linked approximately 36–50 % of gastric adenocarcinomas with characteristics such as intestinal-type histology, chromosomal abnormalities, changes in the receptor tyrosine kinase–RAS signaling pathway, as well as TP53 gene and somatic copy-number aberrations.